Loading market dashboard
AN2 Therapeutics, Inc.
ANTXHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
AN2 Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2028 | $389.90M | $389.90M - $389.90M | $0.00 | -$1.02 | 1 |
| Dec 2027 | $217.00M | $217.00M - $217.00M | $0.00 | -$1.04 | 1 |
| Dec 2026 | $72.70M | $72.70M - $72.70M | $0.00 | -$0.96 | 1 |
| Dec 2025 | $33.20M | $33.20M - $33.20M | $0.00 | -$1.12 | 1 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.724 | 0 |